Trial Profile
A Comparative, Randomized Double Blind Prospective Study to evaluate the use of Dexmedetomidine as adjuvant to Ropivacaine for Transversus Abdominis Plane (TAP) block in patients undergoing in endoscopic Totally Extraperitoneal (TEP) repair of Hernia
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Ropivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- 25 Jan 2013 New trial record